Nova Biomedical
A world leader in critical and point-of-care testing

About Nova Biomedical

Nova Biomedical develops, manufactures, and sells advanced technology blood testing analyzers. We employ over 1,000 people, with sales and service subsidiaries in eight countries and distributors in more than 90 additional countries. Nova has manufacturing facilities in Waltham and Billerica, Massachusetts, Belo Horizonte, Brazil and in Taipei, Taiwan. Nova is one of the 25 largest in vitro diagnostic companies in the world and the largest privately owned in vitro diagnostic company in the United States.

Worldwide Market Areas Include:

Hospital Blood Gas and Critical Care Analyzers
Nova Biomedical is the world technology leader in the development of fast, whole blood analyzers to support the care of hospitalized and critically ill patients. Nova analyzers offer the most extensive stat test menus and deliver results in the shortest time at the lowest costs. Nova also provides handheld meter-and-strip based measuring systems for glucose, ketone, lactate, and creatinine point-of-care testing. Whether testing is performed in the central laboratory or in emergency, surgical, critical, or respiratory care areas, Nova analyzers can help to improve patient outcomes while reducing the cost of care.

Chemistry and Cell Analyzers for Biotechnology
Nova manufactures a series of BioProfile® automated chemistry and cell analysis analyzers for rapid testing of key nutrients, metabolites, gases, and cell status in cell culture and fermentation media.

Self-Testing Diabetes Monitoring Systems
Nova develops and manufactures blood glucose meters and test strips for self-testing by patients with diabetes. The glucose monitoring systems are distributed under the Nova Max® label in the US and Canada, and under the Menarini label in Europe.

Product Development and Manufacturing for Corporate Partners
In addition to Nova products, we develop and manufacture medical devices and diagnostic products for many of the world’s leading healthcare corporations. Nova designs only to the highest standards of quality and reliability, and manufactures at low costs.

Pioneering Technological Innovations
Nova Biomedical has a 35-year history as the world leader in developing whole blood biosensors for clinical and cell culture/fermentation use.

A Global Company

Nova has sales and service operations in 100 countries through Nova subsidiaries or distributors. Nova’s wholly-owned subsidiaries are located in Brazil, Canada, France, Germany, the U.K., Japan, and the U.S., with distributors in 92 additional countries. Nova subsidiaries and distributors provide product information, demonstrations, local product inventory, and complete technical support. Whether you are located in North America, Europe, Russia, Eastern Europe, the Middle East, Africa, Asia, the Pacific Islands, Latin America, or the Indian Subcontinent, Nova can support your point-of-care and critical care testing needs. Nova’s global manufacturing operations take place in four facilities certified by the International Organization for Standardization (ISO) and are located in Waltham and Billerica, Massachusetts, USA; Taipei, Taiwan; and Belo Horizonte, Brazil. These facilities occupy a total of 42,000 square meters (420,000 square feet) of manufacturing space.

Measurement Technologies

Potentiometric (whole blood or plasma)
Amperometric (whole blood/plasma or cell culture media)
Conductivity (whole blood)
Immunochemistry (whole blood or plasma)
Spectrophotometric (plasma and cell culture media)
Photometric (lysed whole blood)
Ellipsometry (saliva/urine)
Imaging (cell culture)

Nova Biomedical Corporation
200 Prospect Street
Waltham MA, 02454-9141. USA
Telephone: (781) 894-0800
FAX: (781) 894-0800
E-mail: info@novabiomedical.com